Thursday , September 20 2018
Home / Letter From The Editor / Letter from the Editor #599

Letter from the Editor #599

Nov 12, 2011

This week we are headlining the break-up of the Lilly-Amylin alliance and how that might affect the anticipated sales of the hopefully soon-to-be-approved Bydureon. Most of us found it hard to believe that after all this time that Lilly would give up on the exenatide franchise but when you examine the details of their disengagement you might be interested in what you find.

If you take the time to look at Item #6,  you will find that Sleep Apnea Increases Hypos and Autonomic Dysfunction in our patients. This can be added to a long list of problems that are associated with sleep apnea. During some recent research I was doing for an education program I found that 50% of all patients with sleep apnea have hypertension and that 50% of all hypertensive patients have sleep apnea, but the majority of them are undiagnosed. If you want a little more information check out these slides describing the relationship.



TODAY! TCOYD Conference and Health Fair, San Diego Convention Center, San Diego, California, Saturday, November 12, 2011

Join Steven Edelman, MD and Charlie Kimball, IZOD Indy Car Driver; Phil Southerland, Professional Cyclist, Founder, Team Type 1; and Ben Vereen, Singer, Dancer, and Actor, for a day focused on diabetes health and wellness. November 13, 7PM ET on CNBC

Topics: dLife heads to Capitol Hill to visit the JDRF Children’s Congress, and to see what progress diabetes advocates are making in Washington. Plus, Jim Turner asks: “What’s the most insensitive thing someone has said about your diabetes?” Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on

Please answer this week’s poll: Should insulin therapy be used earlier in the treatment of diabetes?

Vote in and then see results from previous polls here.

We can make a difference!

Check out this week’s “Test Your Diabetes Knowledge” question!

Dave Joffe, Editor-in-chief